ArticleAmerican journal of translational research2021
The impact of diagnosis related group payment on the performance of public hospitals.
Article in American journal of translational research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Changes in Hospitalization Expenditures and Length of Stay for Patients Underwent Hysterectomy and Adnexectomy for Carcinoma in situ and Nonmalignant Lesions Diagnosis-Related Group: Impact of Beijing's Medicine-Consumables Linkage Reforms.Risk management and healthcare policy · 2026Article
- The moderating role of the case-mix index in the relationship between medical staff allocation and average cost per inpatient visit.Frontiers in public health · 2026Article
- Correlation Between Diagnosis-Related Group Weights and Nursing Time in the Cardiology Department: Cross-Sectional Study.JMIR medical informatics · 2025Article
- Cost shifting or cost cutting by hospitals as a response to reimbursement reform? The case of diagnosis-related groups (DRG) scheme in China.Frontiers in public health · 2025Article
- The impact of diagnosis-related group payment on the hospitalization expenditure and medical quality of public hospitals in China.PloS one · 2025Article
- Evaluation of the effect of DRG payment policy based on interrupted time series modeling: evidence from a tertiary hospital in Anhui Province.Health research policy and systems · 2024Article
- DRGKB: a knowledgebase of worldwide diagnosis-related groups' practices for comparison, evaluation and knowledge-guided application.Database : the journal of biological databases and curation · 2024Article
- Optimizing the management of electrophysiology labs in Chinese hospitals using a discrete event simulation tool.BMC health services research · 2024Article
- Impact of Medical-Pharmaceutical Separation Reform on Hospitalization Expenditure in Tertiary Public Hospitals: Difference-in-Difference Analysis Based on Panel Data from Beijing.Risk management and healthcare policy · 2024Article
- Development of an assessment tool for designated medical institutions in China--Based on the application of an online assessment system.Frontiers in public health · 2024Article
- Article
- Comparison between the General Assessment of Hospitalised Patient Tool and the Barthel Index: A Retrospective Study.Nursing reports (Pavia, Italy) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo investigate the practical value of diagnosis related groups (DRGs) according to payment for assessing the performance of public hospitals.
methodsAccording to a random number table, 2400 patients were chosen from 3928 inpatients admitted for treatment in our hospital. Based on nodes implemented in the DRGs, these patients were assigned to the control group and the experimental group (1200 patients in each group). In the control group, patients didn't receive assistance with DRG payment (a clinical performance management approach was carried out based on the type of disease and cost), while patients in the experimental group received DRG. Bed turnover rate, hospitalization time, average cost, mortality, and subjective satisfaction were obtained and compared between the two groups.
resultsCompared with the control group, bed turnover rate, hospitalization time, average cost, and mortality in the experimental group were all significantly decreased (P<0.05), while subjective satisfaction was increased (P<0.05).
conclusionDRG payment is beneficial for reduced clinical hospitalization time, cost, and mortality, and improved bed utilization rate and subjective satisfaction, which is worthy of clinical promotion.
Indexed as
Identifiers
34306429PMC8290653What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.